Student Zoe Davis, 20, was just weeks into her junior year when she landed back in the hospital with severe sickle cell pain ...

AbbVie on Friday said the application covers telisotuzumab vedotin, or teliso-V, in adults with previously treated, locally advanced or metastatic epidermal growth factor receptor wild type, ...

Results from TEMPO-1, which showed that tavapadon significantly improved motor symptoms in patients with Parkinson’s disease, ...

The PowerA OPS v1 is a wireless PC controller that's also compatible with mobile devices and cloud gaming services. Being a ...

Survival rates for aggressive lymphomas have improved significantly thanks to advances in treatment, such as chimeric antigen receptor-T cell therapy (CAR-T cell therapy). Dr. Madiha Iqbal, a Mayo ...

Glioblastoma is the most common and most aggressive primary brain tumor, with an average survival after diagnosis of less than two years, and against which current treatments remain ineffective.

Stimulating a key metabolic pathway in T cells can make them work more effectively against tumors when combined with immune ...

Researchers have developed a promising CAR-T cell therapy targeting glioblastoma, the most aggressive brain tumor.

Scientists at UNIGE and HUG have developed CAR-T cells capable of targeting malignant gliomas while preserving healthy tissue ...

This 5-foot-8 model is wearing the Uniqlo Supima Cotton Crew Neck T-Shirt in a size M. Photo: Marki Williams This 5-foot-5 model is wearing the Lady White Co. T-Shirt in a size S. Photo ...

©News Group Newspapers Limited in England No. 679215 Registered office: 1 London Bridge Street, London, SE1 9GF. "The Sun", ...

At the IAA Transportation 2024 in Hannover, SINOTRUK showcases seven advanced models including Yellow River with ultra-low ...